Index by author
Alraies, M. Chadi
- You have accessUnmasking gastric cancerFaysal Altahawi, Abdul Hamid Alraiyes, MD and M. Chadi Alraies, MD, FACPCleveland Clinic Journal of Medicine September 2011, 78 (9) 606-608; DOI: https://doi.org/10.3949/ccjm.78a.10129
Screening with diagnostic imaging may be justified in high-risk groups, although the issue is debatable.
Alraiyes, Abdul Hamid
- You have accessUnmasking gastric cancerFaysal Altahawi, Abdul Hamid Alraiyes, MD and M. Chadi Alraies, MD, FACPCleveland Clinic Journal of Medicine September 2011, 78 (9) 606-608; DOI: https://doi.org/10.3949/ccjm.78a.10129
Screening with diagnostic imaging may be justified in high-risk groups, although the issue is debatable.
Altahawi, Faysal
- You have accessUnmasking gastric cancerFaysal Altahawi, Abdul Hamid Alraiyes, MD and M. Chadi Alraies, MD, FACPCleveland Clinic Journal of Medicine September 2011, 78 (9) 606-608; DOI: https://doi.org/10.3949/ccjm.78a.10129
Screening with diagnostic imaging may be justified in high-risk groups, although the issue is debatable.
Dao, Carol
- You have accessOral plaques and dysphagia in a young manAmber S. Tully, MD and Carol Dao, MDCleveland Clinic Journal of Medicine September 2011, 78 (9) 594-596; DOI: https://doi.org/10.3949/ccjm.78a.10150
A 23-year-old man presents with oral plaques, a sore throat, dysphagia, malaise, and weight loss. What is the most likely diagnosis?
Hsieh, Fred H.
- You have accessAllergy blood testing: A practical guide for cliniciansRoxana I. Siles, MD and Fred H. Hsieh, MDCleveland Clinic Journal of Medicine September 2011, 78 (9) 585-592; DOI: https://doi.org/10.3949/ccjm.78a.11023
These tests can confirm the diagnosis of an allergic disorder, supplementing the clinical history. They are particularly useful when skin testing cannot or should not be done.
Kaatz, Scott
- You have accessVenous thromboembolism: What to do after anticoagulation is startedScott Kaatz, DO, MSc, FACP, Waqas Qureshi, MD and Robert C. Lavender, MD, FACPCleveland Clinic Journal of Medicine September 2011, 78 (9) 609-618; DOI: https://doi.org/10.3949/ccjm.78a.10175
Three issues need to be addressed: the length of therapy, measures to prevent postthrombotic syndrome, and a basic workup for possible underlying malignancy.
Lavender, Robert C.
- You have accessVenous thromboembolism: What to do after anticoagulation is startedScott Kaatz, DO, MSc, FACP, Waqas Qureshi, MD and Robert C. Lavender, MD, FACPCleveland Clinic Journal of Medicine September 2011, 78 (9) 609-618; DOI: https://doi.org/10.3949/ccjm.78a.10175
Three issues need to be addressed: the length of therapy, measures to prevent postthrombotic syndrome, and a basic workup for possible underlying malignancy.
Longworth, David L.
- You have accessAccountable care organizations, the patient-centered medical home, and health care reform: What does it all mean?David L. Longworth, MDCleveland Clinic Journal of Medicine September 2011, 78 (9) 571-582; DOI: https://doi.org/10.3949/ccjm.78gr.11003
Central to fixing the broken US health care system are two concepts: the patient-centered medical home and accountable care organizations.
Mandell, Brian F.
- You have accessWhen to stop treating the bonesBrian F. Mandell, MD, PhDCleveland Clinic Journal of Medicine September 2011, 78 (9) 563; DOI: https://doi.org/10.3949/ccjm.78b.11009
Don’t let the argument about how long to treat osteoporosis with bisphosphonate drugs stand in the way of initiating therapy in patients at risk of fracture.
Ott, Susan M.
- You have accessWhat is the optimal duration of bisphosphonate therapy?Susan M. Ott, MDCleveland Clinic Journal of Medicine September 2011, 78 (9) 619-630; DOI: https://doi.org/10.3949/ccjm.78a.11022
It is reasonable to stop bisphosphonates after 5 years of use and then to follow patients with markers of bone turnover.